IDH1 and glioma: By applying Time-Dependent receiver operating characteristic (timeROC) curve and GSVA method, we ascertained a seven-gene signature as an independent prognostic factor, which could accurately predict the 3 years and 5 years overall survival for patients with IDH-mutant glioma.